Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedResults Submitted is now shown, indicating that the study's results have been submitted and are reflected on the page. The record's revision tag advanced to v3.6.5, replacing the previous 'No Results Posted' status and v3.6.4.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a minor update to the page without changing the study information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3. This indicates a small update to the page rather than new study information.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision changed from v3.6.0 to v3.6.2, signaling a small maintenance update rather than changes to the study content.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now indicates that recruitment has closed and adds several help/navigation items, along with a label formatting change for Intervention/Treatment and an update from revision v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check77 days agoChange DetectedThe revision history shows the page updated from v3.5.4 to v3.5.5, indicating a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.0%

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.